Should I Buy EPC? EPC 2026 Analysis

Should You Buy Edgewell Personal Care Co (EPC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

20.750

1 Day change

1.37%

52 Week Range

32.960

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now: the stock is short-term stretched (RSI ~~82) and sitting right under resistance (~~$20.45–$20.98), which limits immediate upside for an impatient entry.
Near-term risk/reward is skewed against chasing here with earnings on 2026-02-09 pre-market and extremely elevated implied volatility.
If you already own it: hold for now, but expect choppiness into earnings; if you don’t own it: avoid initiating at $20.40 and look for a better entry after earnings or on a pullback toward ~$19.60.

Technical Analysis

Trend/Momentum: MACD histogram is positive and expanding (bullish momentum), but the move is overheated (RSI_6 = 81.97, overbought).
Moving averages: converging MAs suggest the trend is not firmly established; price strength may be near-term news-driven rather than a sustained uptrend.
Key levels: Pivot $19.605 (important near-term support). Resistance: R1 $20.453 (current price is just below), then R2 $20.977.
Pattern-based forward look (provided): 90% chance of -0.65% next day, -0.53% next week, +3.54% next month (near-term drift down, medium-term recovery bias).

Intellectia Proprietary Trading Signals

AI Stock Picker: No signal on given stock today.
SwingMax: No signal on given stock recently.

Options Data

Bullish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

Positioning vs flow: Open interest put/call = 0.55 suggests more call positioning (mildly bullish), but today’s volume put/call = 2.0 shows puts dominated today’s flow (more hedging/bearish near-term sentiment).
Volatility: 30D IV ~103.48 vs historical vol ~27.63 (very large premium), consistent with a major event window (earnings 2026-02-09).
Liquidity/interpretation caution: absolute options volume is tiny (todays_volume = 3), so the put-heavy volume signal may be noisy; still, the IV spike indicates the market is pricing a big move.

Technical Summary

Sell

Buy

Positive Catalysts

- 2026-02-02: Completed sale of feminine care business to Essity for $340M—balance sheet strengthening and debt paydown is a clear positive catalyst.
- Strategic focus: Management messaging emphasizes transformation and focus on core categories (shaving, sun, skin care), which can improve long-term margin profile.
- Upcoming disclosure: Additional unaudited sale-related financial info expected by Feb 6 may reduce uncertainty and improve transparency.

Neutral/Negative Catalysts

- Earnings catalyst risk: QDEC 2025 earnings on 2026-02-09 pre-market; with IV extremely high, the stock can swing sharply.
- Short-term technical risk: overbought RSI near resistance increases probability of a pullback/consolidation.
- Options flow today leaned defensive (put volume > call volume), hinting at near-term caution/hedging despite call-heavy open interest.
- No supportive “smart money” trend signals: hedge funds/insiders reported as neutral recently; no politician/congress activity to corroborate a conviction move.

Financial Performance

Latest quarter: 2025/Q4.
Revenue: $537.2M, +3.79% YoY (top-line growth positive).
Profitability deteriorated sharply: Net income -$30.6M (down -447.73% YoY) and EPS -$0.66 (down -466.67% YoY).
Margins: Gross margin 38.83%, down -8.76% YoY—suggests cost pressure/mix issues and explains why Wall Street remains cautious near-term even with revenue growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Trend: Analysts have been cutting price targets into late 2025/early 2026 after a weak quarter and softer guidance.
Recent actions:
- Wells Fargo (2026-01-05): PT cut to $20 from $23, kept Overweight.
- Morgan Stanley (2025-11-18): PT cut to $21 from $23, kept Equal Weight.
- RBC (2025-11-14): PT cut to $23 from $26, kept Outperform (longer-term improvement expected, limited near-term upside).
- Barclays (2025-11-14): PT cut to $19 from $22, kept Equal Weight.
- Wells Fargo (2025-11-14): PT cut to $23 from $25, kept Overweight.
Wall Street pros/cons snapshot: Pros—portfolio simplification and potential for better long-run growth/margins post-divestiture. Cons—near-term profitability and guidance concerns; targets cluster around $19–$23, and the stock at ~$20.4 sits close to the middle of that band (not an obvious “mispriced bargain” today).

5 Analyst Rating

Wall Street analysts forecast EPC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EPC is 23.6 USD with a low forecast of 19 USD and a high forecast of 32 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

2 Hold

0 Sell

Moderate Buy

Current: 20.470

Low

Averages

23.6

High

Current: 20.470

Low

Averages

23.6

High

Wells Fargo

Overweight

downgrade

$23 -> $20

AI Analysis

2026-01-05

Reason

Wells Fargo

Price Target

$23 -> $20

AI Analysis

2026-01-05

downgrade

Overweight

Reason

Wells Fargo lowered the firm's price target on Edgewell Personal Care to $20 from $23 and keeps an Overweight rating on the shares. As Wells aggregates models across Beverage/Food/HPC, the firm is revising its price targets into 2026.

Morgan Stanley

Equal Weight

downgrade

$23 -> $21

2025-11-18

Reason

Morgan Stanley

Price Target

$23 -> $21

2025-11-18

downgrade

Equal Weight

Reason

Morgan Stanley lowered the firm's price target on Edgewell Personal Care to $21 from $23 and keeps an Equal Weight rating on the shares following a fiscal Q4 miss and lower than expected FY26 guidance.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for EPC

Unlock Now

EPC Should I Buy

EPC Should I Buy

Should You Buy Edgewell Personal Care Co (EPC) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch